Association Between 18F-FDG Avidity and the BRAF Mutation in Papillary Thyroid Carcinoma

The BRAF mutation, a potential prognostic factor in papillary thyroid carcinoma (PTC), is associated with a high expression of the glucose transporter gene. We investigated which clinicopathologic factors, including BRAF mutation status, influence 18F-fluoro-2-deoxyglucose (18F-FDG) avidity